- Home
- Slides
- Home
- Tools and Resources
- Research Summaries for Consumers, Clinicians, and Policymakers
- Search for Research Summaries, Reviews, and Reports
- Research Available for Comment
- Submit a Suggestion for Research
- Submit Scientific Information Packets
- Comparative Effectiveness Research Grant and ARRA Awards
- News and Announcements
- What Is Comparative Effectiveness Research
- Who Is Involved in the Effective Health Care Program
- What Is the Effective Health Care Program
Slides
Slides: 1–12 of 29
Management of Chronic Kidney Disease Stages 1–3
Keywords: comparative effectiveness review | screening | monitoring | treatment | chronic kidney disease
Outline of Material
Keywords: comparative effectiveness review | screening | monitoring | treatment | chronic kidney disease
Agency for Healthcare Research and Quality (AHRQ) Comparative Effectiveness Review (CER) Development
Strength of Evidence Ratings
Keywords: comparative effectiveness review | CER | strength of evidence
Background: Chronic Kidney Disease Stages
Keywords: chronic kidney disease | stages | definitions
Background: Public Health Impact
Keywords: chronic kidney disease | prevalence | stages | risk factors
Background: Risk Factors and Comorbidities
Keywords: chronic kidney disease | prevalence | comorbidity | risk factors
Background: Associated Adverse Outcomes
Keywords: adverse outcomes | chronic kidney disease
Factors That Impact Potential Benefit of Screening Adults for CKD Stages 1–3
Keywords: screening | chronic kidney disease
Clinical Questions Addressed in the CER: Treatments for CKD Stages 1–3
Keywords: comparative effectiveness | chronic kidney disease | treatment | adverse effects
Clinical Questions Addressed in the CER: Clinical Outcomes of Interest From Treatments
Clinical Questions Addressed in the CER: Screening and Monitoring
Keywords: adverse effects | adverse effects | benefits | clinical outcomes | harms | monitoring | screening
Your slide tray is being processed.


E-mail Updates










